BILTHOVEN, the Netherlands, Feb. 23, 2021 /PRNewswire/ — Intravacc, a world chief in translational analysis and improvement of vaccines, immediately introduced the formation of a Scientific Advisory Board (“SAB”), chaired by Intravacc’s Chief Scientific Officer Virgil Schijns and additional comprising scientific leaders within the fields of vaccinology, infectious ailments and oncology. Intravacc’s SAB will probably be consulted to assist outline the right vaccine methods and options to ascertain an influence on public well being supported by convincing scientific scientific knowledge. The SAB may even advise on the corporate’s analysis technique and approaches to optimize remedy effectiveness and added worth.
Prof. Dr. Virgil Schijns, Intravacc’s Chief Scientific Officer, commented:
“We’re delighted to launch our Vaccine Scientific Advisory Board with these spectacular scientists as constitution members. We view their settlement to advise us on the event of our groundbreaking multiplatform vaccines as a vote of confidence in our expertise. This distinguished group of scientific leaders can present Intravacc with extremely valued counsel and steering as we proceed increasing our contract improvement and manufacturing franchise, together with our pioneering endeavors in therapeutic vaccines“.
Prof. Dr. Evelien Smits is analysis professor in tumor immunology and most cancers immunotherapy on the College of Antwerp, Belgium. She is researching how the immune system of most cancers sufferers could be supplied with the required weapons to win the battle towards most cancers cells.
Dr. Harry Flore is Chairman of the Supervisory Board of HAL Allergy Holding of Leiden, the Netherlands – one in all Europe’s prime gamers within the subject of allergen immunotherapy, and a world chief within the manufacturing of modified allergen extracts for each therapeutic and diagnostic functions. He’s additionally energetic in HALIX, a CDMO, specializing in cell culture-based pharmaceutical manufacturing.
Prof. Dr. Anke Huckriede is Professor of Vaccinology on the College of Groningen, the Netherlands, and is affiliated with the College Medical Heart Groningen. Huckriede’s analysis actions are aimed toward vaccine improvement, with a give attention to rational vaccine design. Her work on (influenza) vaccines focuses, amongst different issues, on growing in vitro strategies for vaccine analysis and understanding the consequences of pre-existing immunity on responses to vaccination.
Dr. Paul Wichgers Schreur is a senior scientist within the subject of arbovirology at Wageningen Bioveterinary Analysis (WBVR). Utilizing strategies like reverse-genetics, single-molecule microscopy, and bacterial superglue he research the an infection cycle of bunyaviruses and makes use of this information to (co)develop therapeutic antibodies and vaccines.
Dr. Marien de Jonge is Affiliate Professor at Radboud College Medical Heart, appearing as Head of the Pediatric Infectious Illnesses Part. He has greater than 15 years of expertise in each educational analysis and industrial R&D, primarily within the subject of vaccine improvement and infectious ailments.
Dr. Paul Oostvogel M.D. is medical microbiologist. He has been concerned within the Polio Eradication Initiative from the beginning in 1989. He retired in 2019 as head of the Public Well being Laboratory of the Public Well being Service (GGD) Amsterdam.
Dr. Jan Groen, Intravacc’s CEO, stated:
“I’m delighted to have such an achieved and various group of scientific, scientific and trade specialists as inaugural members of our Scientific Advisory Board. Their experience will guarantee our actions stay firmly primarily based on sound science and can assist us uncover new alternatives for vaccine innovation.”
About Intravacc
Dutch Intravacc, situated at Utrecht Science Park Bilthoven, is a number one international contract developer and producer of revolutionary vaccines towards infectious ailments. As a longtime unbiased CDMO group with over 100 years of expertise within the improvement and optimization of vaccines and vaccine applied sciences, Intravacc has transferred its expertise associated to polio vaccines, measles vaccines, DPT vaccines, Hib vaccines and influenza vaccines around the globe. Round 40% of childhood illness vaccines are primarily based on Intravacc’s expertise. Intravacc gives a variety of experience for unbiased vaccine improvement, from idea to Part I/II scientific research for companions around the globe, together with universities, public well being organizations (WHO, Invoice & Melinda Gates Basis), biotech and pharmaceutical corporations.
For extra info, go to www.intravacc.nl
Contacts:
Intravacc
Dr. Jan Groen, CEO
P: +31 30 7920 454
Mirjam Hartman, Media relations
P: +31 6 115 969 94
E: [email protected]
LifeSpring Life Sciences Communication, Amsterdam
Leon Melens
P: +31 6 538 16427
E: [email protected]
SOURCE Intravacc B.V.
